Literature DB >> 6965596

Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells.

M A Moore, H E Broxmeyer, A P Sheridan, P A Meyers, N Jacobsen, R J Winchester.   

Abstract

The presence of Ia-like antigens on human CFU-C and BFU-e is confirmed and a cell type that lacked immediate capacity for granulocytic colony formation but generated CFU-c after brief incubation in simple suspension culture is identified. This pre-CFU-c, and its immediate progeny, was extremely sensitive to killing by anti-Ia serum with complement. In contrast, anti-Ia serum plus complement treatment of human bone marrow, while eliminating 93%-97% of all CFU-c and BFU-e, did not prevent the rapid regeneration of these progenitor cells and their production for some weeks under the conditions of continuous marrow culture. These studies suggest that the human equivalent of the pluripotential stem cell can replicate for some weeks in culture and generate committed progenitors, such as CFU-c and BFU-e. Furthermore, it would appear that Ia-like antigen is absent on the pluripotential stem cell, is rapidly gained as commitment to the various progenitor cell types occur, and is subsequently lost as these latter undergo differentiation within the marrow.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965596

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Self-induction of a/a or alpha/alpha biofilms in Candida albicans is a pheromone-based paracrine system requiring switching.

Authors:  Song Yi; Nidhi Sahni; Karla J Daniels; Kevin L Lu; Guanghua Huang; Thyagarajan Srikantha; David R Soll
Journal:  Eukaryot Cell       Date:  2011-04-15

2.  Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro.

Authors:  J Brandt; N Baird; L Lu; E Srour; R Hoffman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  In vitro hemopoiesis in human micro long-term bone marrow cultures recharged with either allogeneic, T-cell-depleted allogeneic, or syngeneic bone marrow cells.

Authors:  H G Mergenthaler; P Dörmer
Journal:  Blut       Date:  1990-04

4.  Inhibitory effect of a human T cell hybrid factor on both cell growth and mixed lymphocyte reactivity. Correlation with class II molecule expression.

Authors:  M Trucco; S Shaw; R Korngold
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

Review 5.  Characterization of hematopoietic stem and progenitor cells.

Authors:  D E Williams; L Lu; H E Broxmeyer
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

6.  Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.

Authors:  H Zola; P J McNamara; H A Moore; I J Smart; D A Brooks; I G Beckman; J Bradley
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

7.  Association between colony forming units-granulocyte macrophage expression of Ia-like (HLA-DR) antigen and control of granulocyte and macrophage production. A new role for prostaglandin E.

Authors:  L M Pelus
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

8.  CFU-c enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque.

Authors:  G M Georgiou; D M Roberton; W M Ellis; B J Shen; H Ekert; C S Hosking
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

9.  Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed.

Authors:  I D Bernstein; J W Singer; R G Andrews; A Keating; J S Powell; B H Bjornson; J Cuttner; V Najfeld; G Reaman; W Raskind
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

10.  An assessment of the ability of human bone marrow cultures to generate osteoclasts.

Authors:  A M Flanagan; M A Horton; E L Dorey; D A Collins; R S Evely; J M Moseley; F C Firkin; T J Chambers; M H Helfrich; T J Martin
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.